Cancer Survival Rates Keep Climbing Thanks to Clinical Trials

More people are surviving cancer than ever before, and the steady climb in survival rates shows no signs of slowing down.

The credit goes to cancer researchers developing breakthrough treatments and the thousands of patients who volunteer for clinical trials. These studies test new medications, surgical techniques, and therapies in humans before they become widely available, serving as the crucial final step in turning laboratory discoveries into real-world cancer treatments.

Clinical trials have revolutionized cancer care over the past few decades. They introduced immunotherapy, which supercharges the immune system to fight cancer cells, and antibody drug conjugates that deliver chemotherapy precisely where it's needed. The latest wave focuses on cell therapies like CAR T cells, offering fresh hope for patients who've run out of options.

Dr. Jennifer Diamond, medical director of the Cancer Clinical Trials Office at the University of Colorado Anschutz Cancer Center, emphasizes that surviving cancer is about more than just staying alive. Quality of life matters just as much as quantity.

Researchers now focus heavily on helping survivors manage side effects and reclaim their daily lives. New trials test medications for hot flashes from breast cancer treatments and explore solutions for pain, nausea, and the extreme fatigue that often lingers after treatment ends.

The CU Anschutz Cancer Center stands as one of only 58 National Cancer Institute-designated comprehensive cancer centers nationwide. This prestigious designation means the center meets rigorous standards for cutting-edge research and offers patients access to trials ranging from homegrown studies to national investigations.

The Ripple Effect

Every person who volunteers for a clinical trial becomes part of something bigger than themselves. They spend extra hours at medical centers, complete additional questionnaires, and undergo extra procedures, all to pave the way for better treatments down the road.

These volunteers and their supportive families make every cancer treatment advance possible. Without their willingness to participate, the promising therapies being developed in labs would never reach the patients who desperately need them.

Patients don't need to travel to specialized cancer centers to learn about trial opportunities. Diamond encourages everyone diagnosed with cancer to ask their physician whether a clinical trial might be right for them, and seeking a second opinion at comprehensive cancer centers remains always an option.

The steady improvement in cancer outcomes represents thousands of small victories won by researchers and volunteers working together toward a common goal.